Cited 48 time in
The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shen, Jie | - |
| dc.contributor.author | Park, Hyeon-soo | - |
| dc.contributor.author | Xia, Yong-mei | - |
| dc.contributor.author | Kim, Gon-sup | - |
| dc.contributor.author | Cui, Steve W. | - |
| dc.date.accessioned | 2022-12-26T23:17:03Z | - |
| dc.date.available | 2022-12-26T23:17:03Z | - |
| dc.date.issued | 2014-03-15 | - |
| dc.identifier.issn | 0144-8617 | - |
| dc.identifier.issn | 1879-1344 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/19097 | - |
| dc.description.abstract | Medicinal mushroom polysaccharides such as Ganoderma lucidum polysaccharides (GLPs) have been commonly hypothesized to suppress tumor cells proliferation through immune effects. To verify this hypothesis through investigating comprehensive miRNA expression in polysaccharide treated cancer cells, an anticancer mycelia GLP was employed to disclose miRNA differential expression of human hepatocarcinoma cells (HepG2), by using a miRNA microarray assay based on Sanger miR-Base Release 16. The experiment and the analysis result indicates that among the 61 differential expressed miRNAs (p <= 0.01), 17 of them were regulated significantly. GLP can inhibit HepG2 cells directly through regulation of hepatocarcinoma genes. A newly found miR-3131 exhibited the strongest upregulation (92-folds, Log 2 = 6.53, p=0.000016). The miRNAs responded synergistically in both hepatocarcinoma and immune-related aspects. (C) 2014 Elsevier Ltd. All rights reserved. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER SCI LTD | - |
| dc.title | The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1016/j.carbpol.2013.12.044 | - |
| dc.identifier.scopusid | 2-s2.0-84892148938 | - |
| dc.identifier.wosid | 000332812600042 | - |
| dc.identifier.bibliographicCitation | CARBOHYDRATE POLYMERS, v.103, pp 319 - 324 | - |
| dc.citation.title | CARBOHYDRATE POLYMERS | - |
| dc.citation.volume | 103 | - |
| dc.citation.startPage | 319 | - |
| dc.citation.endPage | 324 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalResearchArea | Polymer Science | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
| dc.relation.journalWebOfScienceCategory | Polymer Science | - |
| dc.subject.keywordPlus | MICRORNA EXPRESSION PROFILES | - |
| dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
| dc.subject.keywordPlus | CIRCULATING MICRORNAS | - |
| dc.subject.keywordPlus | MIR-122 | - |
| dc.subject.keywordPlus | HEPATOCARCINOMA | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | TARGETS | - |
| dc.subject.keywordAuthor | Polysaccharide | - |
| dc.subject.keywordAuthor | miRNA | - |
| dc.subject.keywordAuthor | Antitumor | - |
| dc.subject.keywordAuthor | Hepatocarcinoma | - |
| dc.subject.keywordAuthor | Ganoderma lucidum | - |
| dc.subject.keywordAuthor | Immune | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
